29 June 2012
Tacrolimus-induced nephrotoxicity and genetic variability: A review
Violette M.G.J. Gijsen, Parvaz Madadi, Marie-Pierre Dube, Dennis A. Hesselink, Gideon Koren, Saskia N. de WildtDOI: 10.12659/AOT.883229
Ann Transplant 2012; 17(2): 111-121
Related articles
27 Aug 2019 : Original article
A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study
Jérôme Dumortier, Christophe Duvoux
DOI: 10.12659/AOT.916041
Ann Transplant 2019; 24:506-516
14 Nov 2017 : Original article
Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients
Benjamin Daniel Fox, Fadi Ashquar
DOI: 10.12659/AOT.904417
Ann Transplant 2017; 22:677-681
23 May 2017 : Original article
Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression
Pedro W. Baron, Sergio Infante
DOI: 10.12659/AOT.903079
Ann Transplant 2017; 22:309-314
09 Aug 2016 : Original article
Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms
Yoichi Miyata, Nobuhisa Akamatsu
DOI: 10.12659/AOT.898358
Ann Transplant 2016; 21:491-499
16 Dec 2016 : Original article
Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients
Prajej Ruangkanchanasetr, Natthi Sanohdontree
DOI: 10.12659/AOT.900638
Ann Transplant 2016; 21:765-774
22 Mar 2016 : Original article
Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation
Gerold Thölking, Lea Siats
DOI: 10.12659/AOT.895898
Ann Transplant 2016; 21:167-179
16 Feb 2016 : Original article
Tacrolimus Trough Levels as a Risk Factor for Acute Rejection in Renal Transplant Patients
José Manuel Arreola-Guerra, Marcos Serrano
DOI: 10.12659/AOT.895104
Ann Transplant 2016; 21:105-114
17 Mar 2014 : Original article
An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients
Lars Bäckman, Carl-Axel Persson
DOI: 10.12659/AOT.890101
Ann Transplant 2014; 19:138-144
23 Jun 2014 : Original article
Incidence of malignant neoplasia after heart transplantation – a comparison between cyclosporine a and tacrolimus
Uwe Fuchs, Sarah Klein
DOI: 10.12659/AOT.890199
Ann Transplant 2014; 19:300-304
07 Feb 2014 : Original article
Effect of different tacrolimus levels on early outcomes after kidney transplantation
Shehzad Rehman, Xuerong Wen
DOI: 10.12659/AOT.889858
Ann Transplant 2014; 19:68-75
12 May 2014 : Original article
Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats
Ivan Matia, Peter Fellmer
DOI: 10.12659/AOT.889870
Ann Transplant 2014; 19:225-232
29 Jul 2013
A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up
Bartosz Foroncewicz, Krzysztof Mucha
DOI: 10.12659/AOT.883986
Ann Transplant 2013; 18:384-392
06 Sep 2017 : Clinical Research
Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Function
Brankica Spasojević-Dimitrijeva, Jelena Kotur-Stevuljević
DOI: 10.12659/MSM.903255
Med Sci Monit 2017; 23:4299-4305
26 Sep 2012
Influence of conversion from cyclosporine A to tacrolimus on insulin sensitivity assessed by euglicaemic hyperinsulinemic clamp technique in patients after kidney transplantation
Maciej Bułanowski, Jerzy Chudek
DOI: 10.12659/AOT.883459
Ann Transplant 2012; 17(3): 61-68
14 Jul 2014 : Original article
The Pharmacokinetics of Everolimus in De Novo Kidney Transplant Patients Receiving Tacrolimus: An Analysis from the Randomized ASSET Study
Lionel Rostaing, Maarten H.L. Christiaans
DOI: 10.12659/AOT.890673
Ann Transplant 2014; 19:337-345
29 May 2008
TCF2 gene mutation leads to nephro-urological defects of unequal severity: an open question
Marco Zaffanello, Milena Brugnara
Med Sci Monit 2008; 14(6): RA78-86
07 Aug 2013
Evolution to twice daily bolus intravenous tacrolimus: Optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant
Gregory I. Snell, Steven Ivulich
DOI: 10.12659/AOT.883993
Ann Transplant 2013; 18:399-407
06 Nov 2013 : Original article
Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injury
Ebru Gok Oguz, Ahmet Kiykim
DOI: 10.12659/MSM.889579
Med Sci Monit 2013; 19:942-948
07 Jul 2014 : Original article
Early Conversion from Twice-Daily Tacrolimus to Once-Daily Extended Formulation in Renal Transplant Patients Before Hospital Discharge
Martin Jannot, Ingrid Masson
DOI: 10.12659/AOT.890262
Ann Transplant 2014; 19:320-324
20 Jun 2014 : Original article
Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation
Tomasz Urbanowicz, Hanna Baszyńska-Wachowiak
DOI: 10.12659/AOT.890268
Ann Transplant 2014; 19:295-299
23 Mar 2011
Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of Tacrolimus in Chinese renal transplant patients
Ping Wu, Xuefeng Ni
Ann Transplant 2011; 16(1): 54-60
30 Dec 2011
Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients
Yuichi Muraki, Masanobu Usui
Ann Transplant 2011; 16(4): 55-62
29 Apr 2008
The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients
Silvia Tirelli, Mariano Ferraresso
Med Sci Monit 2008; 14(5): CR251-254
17 Jun 2008
Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients
Hakeam A. Hakeam, Ahmed H. Al-Jedai
Ann Transplant 2008; 13(2): 46-53
In Press
Original article
Preoperative Evidence-Based Practice for Prevention of Early Postoperative Infections in Patients Receiving...Ann Transplant In Press; DOI: 10.12659/AOT.943610
Original article
Prediction of Renal Graft Function 1 Year After Adult Deceased-Donor Kidney Transplantation Using Variables...Ann Transplant In Press; DOI: 10.12659/AOT.944603
Original article
Impact of Donor-Recipient Relationship on Long-Term Outcomes in Living-Related Donor Kidney TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.945065
Case report
Successful Interventional Therapy for Portal Vein Stenosis after Ex Vivo Liver Resection and Autotransplant...Ann Transplant In Press; DOI: 10.12659/AOT.944851
Most Viewed Current Articles
05 Apr 2022 : Original article 12,809
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 9,770
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,215
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,014
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860